Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117941862 | 11794186 | 2 | F | 20151103 | 20160706 | 20151202 | 20160713 | EXP | GB-JNJFOC-20151112541 | JANSSEN | 68.59 | YR | E | F | Y | 71.60000 | KG | 20160713 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117941862 | 11794186 | 1 | PS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | Y | N | 4370965;4370355;21541;23559;23560 | 50718 | LIPOSOME INJECTION | |||||||
117941862 | 11794186 | 2 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | ONCE EVERY 4 WEEKS | Y | N | 4370965;4370355;21541;23559;23560 | 36778 | 70 | MG | LIPOSOME INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117941862 | 11794186 | 2 | Ovarian cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117941862 | 11794186 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117941862 | 11794186 | Anaemia | |
117941862 | 11794186 | Neutropenic sepsis | |
117941862 | 11794186 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117941862 | 11794186 | 2 | 20150331 | 20151022 | 0 |